Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Phio Pharmaceuticals

NASDAQ PHIO
$0.70 -0.07 -9.30%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.64M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-5.82M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.13
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
3.75M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-7.30 %

Upcoming events Phio Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Phio Pharmaceuticals

Stock analysis Phio Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.24 27.58
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.34 3.97
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.55 10.54
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.80 0.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-140.05 10.75

Price change Phio Pharmaceuticals per year

1.57$ 4.36$
Min Max

Summary analysis Phio Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Phio Pharmaceuticals

Revenue and net income Phio Pharmaceuticals

All parameters

Stock news Phio Pharmaceuticals

All news
11 October 2023 в 20:15

Phio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical Data

11 October 2023 в 20:10

Phio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical Data

31 May 2023 в 17:25

Phio Pharmaceuticals Shares Drop 16% After Stock Offerings Price

31 May 2023 в 17:20

Phio Pharmaceuticals Shares Drop 16% After Stock Offerings Price

24 May 2023 в 14:45

Phio Pharmaceuticals Can Begin Trial for Cancer Treatment PH-762

24 May 2023 в 14:45

Phio Pharmaceuticals Can Begin Trial for Cancer Treatment PH-762

17 April 2023 в 18:46

Phio Pharmaceuticals Shares Rise 14% on mPH-762 Model Data

17 April 2023 в 18:40

Phio Pharmaceuticals Shares Rise 14% on mPH-762 Model Data

8 April 2022 в 20:50

Phio Pharmaceuticals Shares Up on Positive Data for PH-894 Cancer Treatment

8 April 2022 в 20:45

Phio Pharmaceuticals Shares Up on Positive Data for PH-894 Cancer Treatment

11 January 2022 в 16:55

Phio Pharmaceuticals Up 8.4% After Clearance for Melanoma Study

11 January 2022 в 16:50

Phio Pharmaceuticals Up 8.4% After Clearance for Melanoma Study

18 November 2019 в 16:33

Лидеры и аутсайдеры Уолл-стрит: Karuna Therapeutics, Caladrius Biosciences, Phio Pharmaceuticals

About company Phio Pharmaceuticals

Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
Address:
257 Simarano Drive, Marlborough, MA, United States, 01752
Company name: Phio Pharmaceuticals
Issuer ticker: PHIO
ISIN: US71880W3034
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2012-05-10
Sector: Healthcare
Industry: Biotechnology
Site: https://www.phiopharma.com

On which stock exchange are Phio Pharmaceuticals (PHIO) stocks traded?

Phio Pharmaceuticals (PHIO) stocks are traded on NASDAQ.

What is the ticker of Phio Pharmaceuticals stocks (PHIO)?

The stock ticker of Phio Pharmaceuticals’s stocks or in other words, the code is PHIO. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Phio Pharmaceuticals (PHIO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Phio Pharmaceuticals (PHIO) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Phio Pharmaceuticals (PHIO) stocks traded?

Phio Pharmaceuticals (PHIO) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Phio Pharmaceuticals (PHIO) stocks today?

The current price of Phio Pharmaceuticals stocks on 14.05.2024 is 0.7045 dollars. per share.

What is the dynamics of Phio Pharmaceuticals (PHIO) stocks from the beginning of the year?

Phio Pharmaceuticals (PHIO) quotes have increased by -8.47% from the beginning of the year up to 0.7045 dollars. per 1 stocks.

How much did Phio Pharmaceuticals (PHIO) stocks increase in мае 2024?

This month Phio Pharmaceuticals (PHIO) quotes have increased by -7.45% to 0.7045 dollars. per share.

How much are Phio Pharmaceuticals (PHIO) stocks worth?

Today, on October, 14.05.2024 Phio Pharmaceuticals’s (PHIO) stocks cost 0.7045 dollars..

What is the market capitalization of Phio Pharmaceuticals (PHIO)?

Capitalization is the market value of Phio Pharmaceuticals (PHIO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Phio Pharmaceuticals (PHIO) is estimated at about 2639993 dollars.